Dr. Sanjib Chowdhury is a Research Assistant Professor for the BU School of Medicine in the Section of Gastroenterology. Dr. Chowdhury received his PhD in Cancer Research and MS in Clinical & Translational Research from the University of Nebraska Medical Center, where he was previously an Assistant Professor of Surgery. He also attended the University of Calcutta where he received an MS & BS in Human Physiology.
- University of Nebraska Medical Center, PhD
- University of Nebraska Medical Center, MS
- University of Calcutta, MSc
- University of Calcutta, BSc
- Published on 1/10/2018
Roy P, Chowdhury S, Roy HK. Exercise-induced myokines as emerging therapeutic agents in colorectal cancer prevention and treatment. Future Oncol. 2018 02; 14(4):309-312. PMID: 29318900.
- Published on 1/3/2018
Somenath Datta, Richard M. Sherva, Mart De La Cruz, Michelle T. Long, Priya Roy, Vadim Backman, Sanjib Chowdhury*, Hemant K. Roy* (*corresponding authors). Single Nucleotide Polymorphism Facilitated Downregulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities. Neoplasia. 2018; (Accepted ).
- Published on 11/1/2017
Caroline M. Robb, Smit Kour, Jacob I. Contreras, Ekta Agarwal, Carter J Barger, Sandeep Rana, Yogesh Sonawane, Beth K. Neilsen, Margaret Taylor, Smitha Kizhake, Rhishikesh N. Thakare, Sanjib Chowdhury, Jing Wang, Jennifer D. Black, Michael A. Hollingsworth, Michael G. Brattain, Amarnath Natarajan. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2017; (Accepted).
- Published on 4/17/2017
Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFß/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. PLoS One. 2017; 12(4):e0176096. PMID: 28414818.
- Published on 4/1/2017
Datta S, Chowdhury S, Roy HK. Metabolism, microbiome and colorectal cancer. Aging (Albany NY). 2017 Apr; 9(4):1086-1087. PMID: 28455972.
- Published on 3/28/2017
Cruz MD, Ledbetter S, Chowdhury S, Tiwari AK, Momi N, Wali RK, Bliss C, Huang C, Lichtenstein D, Bhattacharya S, Varma-Wilson A, Backman V, Roy HK. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis. Oncotarget. 2017 Mar 28; 8(13):20543-20557. PMID: 28423551.
- Published on 3/26/2017
Are C, Meyer B, Stack A, Ahmad H, Smith L, Qian B, Song T, Chowdhury S. Global trends in the burden of liver cancer. J Surg Oncol. 2017 Apr; 115(5):591-602. PMID: 28345140.
- Published on 2/13/2017
Douaiher J, Ravipati A, Grams B, Chowdhury S, Alatise O, Are C. Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol. 2017 Apr; 115(5):619-630. PMID: 28194798.
- Published on 1/30/2017
Are C, Ahmad H, Ravipati A, Croo D, Clarey D, Smith L, Price RR, Butte JM, Gupta S, Chaturvedi A, Chowdhury S. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2017 Apr; 115(5):580-590. PMID: 28138977.
- Published on 1/9/2017
Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. 2017 Jun 01; 36(22):3104-3118. PMID: 28068324.
View 17 more publications: View full profile at BUMC